Recent Updates
Recently added Catalysts
CAPR Negative Sentiment Score: 30/100

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Key Takeaway: Johnson Fistel, PLLP is probing potential legal claims on behalf of Capricor Therapeutics' shareholders related to alleged misconduct by its officers and directors. The investigation focuses on actions that may have adversely affected the company and its investors since before October 9, 2024. Investors are invited to reach out to the firm for guidance on their legal rights and potential changes to corporate governance practices.

Market Sentiment Analysis

CONCERNS & RISKS

  • Allegations of misconduct by Capricor officers and directors.
  • Potential legal claims may indicate internal governance issues.
  • Investors may face continued uncertainty regarding the company's leadership.

Full Press Release Details

SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. (NASDAQ: CAPR) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
Investors who have continuously held Capricor shares since before October 9, 2024, may have legal rights and are encouraged to contact the firm to learn more:
You may be able to pursue changes to the company’s corporate governance practices, seek the recovery of funds for the company, and request a court-approved incentive award, all at no cost to you. Please contact Johnson Fistel at (619) 814-4471 to learn more.
About Johnson Fistel, PLLP:
Johnson Fistel is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in derivative and securities class actions and has recovered over $90 million for clients while earning repeated recognition among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication.
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations, (619) 814-4471

Tags

Frequently Asked Questions

What is Johnson Fistel investigating for Capricor Therapeutics?

They are investigating potential legal claims regarding misconduct by certain Capricor officers and directors.

Who can participate in the investigation?

Investors who held Capricor shares continuously since before October 9, 2024, may have rights.

How can affected investors learn more?

Investors can contact Johnson Fistel at (619) 814-4471 or visit their website.

What can investors seek through this investigation?

Investors may pursue changes in corporate governance, fund recovery, and court-approved awards.

Where is Johnson Fistel located?

They have offices in California, New York, Georgia, and Colorado.

Last updated: Sep 23, 2025